Principle role of the (pro)renin receptor system in cardiovascular and metabolic diseases: An update
Cellular Signalling · 2024
DOI: 10.1016/j.cellsig.2024.111417 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2024. Verfasst von Mengzhi Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China. Hauptthemen laut MEDLINE: Receptors, Cell Surface, Cardiovascular Diseases, Metabolic Diseases, Prorenin Receptor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 251 Literaturangaben.
Abstract (Originalsprache)
(Pro)renin receptor (PRR), along with its soluble form, sPRR, functions not only as a crucial activator of the local renin-angiotensin system but also engages with and activates various angiotensin II-independent signaling pathways, thus playing complex and significant roles in numerous physiological and pathophysiological processes, including cardiovascular and metabolic disorders. This article reviews current knowledge on the intracellular partners of the PRR system and explores its physiological and pathophysiological impacts on cardiovascular diseases as well as conditions related to glucose and lipid metabolism, such as hypertension, heart disease, liver disease, diabetes, and diabetic complications. Targeting the PRR system could emerge as a promising therapeutic strategy for treating these conditions. Elevated levels of circulating sPRR might indicate the severity of these diseases, potentially serving as a biomarker for diagnosis and prognosis in clinical settings. A comprehensive understanding of the functions and regulatory mechanisms of the PRR system could facilitate the development of novel therapeutic approaches for the prevention and management of cardiovascular and metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
- Translational Medicine Centre, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
- Center for Metabolic Disease Research and Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
- Translational Medicine Centre, Jiangxi University of Chinese Medicine, Nanchang 330004, China. Electronic address: chuanming.xu@jxutcm.edu.cn.
Zitieren
APA
Zhu, M., Yi, X., Song, S., Yang, H., Yu, J., & Xu, C. (2024). Principle role of the (pro)renin receptor system in cardiovascular and metabolic diseases: An update. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111417
Vancouver
Zhu M, Yi X, Song S, Yang H, Yu J, Xu C. Principle role of the (pro)renin receptor system in cardiovascular and metabolic diseases: An update. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111417
BibTeX
@article{Zhu2024,
author = {Zhu, Mengzhi and Yi, Xiaoli and Song, Shanshan and Yang, Huiru and Yu, Jun and Xu, Chuanming},
title = {Principle role of the (pro)renin receptor system in cardiovascular and metabolic diseases: An update},
journal = {Cellular Signalling},
year = {2024},
doi = {10.1016/j.cellsig.2024.111417}
}
EUVIMED